Pharma body seeks faster clearances of imported goods at ports

In a letter written on January 27 to the Secretary, Department of Pharmaceuticals, Pharmexcil chairman Dinesh Dua said very critical KSM's (key starting raw materials), Intermediates and API's (active pharmaceutical ingredients) are not being cleared for reasons "not known to the industry at all."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ihPWQ6
via IFTTT